C9ORF41 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.201200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.038200E-01
Normal-vs-Stage2
8.877200E-01
Normal-vs-Stage3
8.331600E-02
Normal-vs-Stage4
3.636600E-01
Stage1-vs-Stage2
4.671400E-01
Stage1-vs-Stage3
1.827670E-02
Stage1-vs-Stage4
5.326200E-01
Stage2-vs-Stage3
6.037700E-02
Stage2-vs-Stage4
1.670650E-01
Stage3-vs-Stage4
3.720400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.372400E-01
Normal-vs-AfricanAmerican
5.084200E-01
Normal-vs-Asian
6.979600E-01
Caucasian-vs-AfricanAmerican
2.013600E-01
Caucasian-vs-Asian
3.576200E-01
AfricanAmerican-vs-Asian
1.594020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.531800E-01
Normal-vs-Female
8.784200E-01
Male-vs-Female
6.698200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.536000E-01
Normal-vs-Age(41-60Yrs)
6.687000E-01
Normal-vs-Age(61-80Yrs)
9.552400E-01
Normal-vs-Age(81-100Yrs)
8.633000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.712400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.984000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.012800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.629900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.748800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.059200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.273000E-01
Normal-vs-Daily Drinker
5.334400E-01
Normal-vs-Weekly Drinker
8.341400E-01
Normal-vs-Occasional Drinker
7.048400E-01
Normal-vs-Social Drinker
6.850400E-01
Non Drinker-vs-Daily Drinker
3.586800E-01
Non Drinker-vs-Weekly Drinker
9.611000E-01
Non Drinker-vs-Occasional Drinker
2.030600E-01
Non Drinker-vs-Social Drinker
1.868360E-01
Daily Drinker-vs-Weekly Drinker
5.011400E-01
Daily Drinker-vs-Occasional Drinker
6.498400E-02
Daily Drinker-vs-Social Drinker
7.121700E-02
Weekly Drinker-vs-Occasional Drinker
3.103400E-01
Weekly Drinker-vs-Social Drinker
2.994200E-01
Occasional Drinker-vs-Social Drinker
8.817000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.280600E-01
Normal-vs-Grade 2
2.025400E-01
Normal-vs-Grade 3
1.305000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.051600E-01
Grade 1-vs-Grade 3
2.074200E-01
Grade 1-vs-Grade 4
3.280600E-01
Grade 2-vs-Grade 3
7.431800E-01
Grade 2-vs-Grade 4
2.025400E-01
Grade 3-vs-Grade 4
1.305000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.425400E-01
Normal-vs-NonDiabetic
9.537000E-01
Diabetic-vs-NonDiabetic
6.512600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.706600E-01
Normal-vs-NoPancreatitis
9.866800E-01
Pancreatitis-vs-NoPancreatitis
3.304800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.021400E-01
Normal-vs-N1
9.002600E-01
N0-vs-N1
9.391000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.652200E-01
Normal-vs-TP53-NonMutant
6.120800E-01
TP53-Mutant-vs-TP53-NonMutant
6.293000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
